Calliditas Therapeutics AB (publ)
CALT · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47 | -$204 | -$18 | -$160 |
| Dep. & Amort. | $0 | $0 | $17 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $53 | $0 |
| Change in WC | -$32 | $14 | -$28 | $60 |
| Other Non-Cash | $73 | $16 | $69 | $37 |
| Operating Cash Flow | -$7 | -$198 | $23 | -$63 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$13 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$4 | $11 | -$7 |
| Investing Cash Flow | -$0 | -$4 | -$2 | -$7 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$5 | $235 | -$3 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$27 | $0 |
| Financing Cash Flow | -$4 | -$5 | $209 | -$3 |
| Forex Effect | -$2 | $44 | -$42 | -$6 |
| Net Chg. in Cash | -$13 | -$163 | $187 | -$79 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $810 | $974 | $787 | $866 |
| End Cash | $797 | $810 | $974 | $787 |
| Free Cash Flow | -$7 | -$198 | $10 | -$63 |